Keyphrases
3′-untranslated Region (3′-UTR)
14%
Alternative Polyadenylation
25%
Alternative Splicing
100%
CELF1
14%
CYP4F
54%
Cytochrome P450 (CYP450)
48%
Deregulation
18%
Drug Metabolism
25%
Eicosanoids
15%
Epithelial Splicing Regulatory Protein
27%
Gene Expression
16%
Gene Regulation
39%
Hepatocytes
43%
Hydroxylase
12%
Inflammation
25%
Kidney
14%
Leukotriene B4 (LTB4)
59%
Light-induced Photoreceptor Degeneration
18%
Lipopolysaccharide
14%
Liver
58%
Liver Maturation
18%
Liver Regeneration
21%
Metabolism
15%
MicroRNA
28%
Mitochondrial Energy Production
18%
Mouse Liver
17%
MRNA Expression
21%
MRNA Stability
13%
Multivalent Ligands
18%
Muscleblind-like
13%
Myotonic Dystrophy
58%
Nuclear Receptor
18%
Oxidative Stress
18%
Post-transcriptional
15%
Post-transcriptional Gene Regulation
13%
Postnatal Heart Development
21%
Protein Expression
14%
Rat Hepatocytes
13%
Rat Kidney
12%
RBFOX2
18%
Retinoid X Receptor
15%
RNA Modification
13%
RNA-binding Protein
51%
Signaling Pathway
22%
Splicing Factor
22%
Therapeutic Agents
16%
Tissue Regeneration
13%
Transcriptome
30%
Traumatic Brain Injury
24%
Type-specific
12%
Biochemistry, Genetics and Molecular Biology
Alternative Splicing
92%
Cardiac Muscle Cell
11%
Cell Cycle
10%
Cell Death
11%
Cell Plasticity
10%
CYP3A
15%
Cytochrome P450
47%
Diptera
10%
Drug Metabolism
21%
Dynamics
26%
Eicosanoid
13%
Energy Yield
18%
Exon
21%
Gene Control
16%
Gene Expression
47%
Genetics
18%
Heart Conduction
10%
Hepatocyte
47%
Hippo Signaling Pathway
10%
Homeostasis
17%
Isoform
39%
Leukotriene B4
15%
Liver Regeneration
29%
Maturation
19%
Messenger RNA
31%
Metabolic Pathway
31%
MicroRNA
27%
Microsatellite DNA
13%
Mouse
64%
Nuclear Receptor
18%
Oxidative Stress
18%
Polyadenylation
19%
Polysome
11%
Precursor mRNA
19%
RNA
64%
RNA Processing
13%
RNA Sequence
15%
RNA Splicing
17%
RNA-binding Protein
49%
Sex Difference
12%
Signal Transduction
12%
Splicing Factor
25%
Stem Cell
18%
Synapsin I
20%
Tissue Regeneration
13%
Tissue Specificity
12%
Transcription
20%
Transcriptome
35%
Trinucleotide Repeat Expansion
13%
Upregulation
11%